Korean Thistle (Cirsium japonicum var. maackii (Maxim.) Matsum.): A Potential Dietary Supplement against Diabetes and Alzheimer’s Disease
Open Access
Abstract
In the search for natural products having a dual inhibitory action on diabetes and Alzheimer’s disease, this study investigated the activity of different parts of Korean thistle (Cirsium japonicum var. maackii (Maxim.) Matsum), and its fractional constituents by in vitro enzymatic and in silico molecular docking studies. Cirsium maackii has been used as a traditional medicine for the treatment of several diseases. The ethyl acetate and dichloromethane fractions of a leaf extract showed α-glucosidase and BACE1 inhibitory activity, respectively. Furthermore, the isolated compound, luteolin, exhibited concentration-dependent non-competitive inhibition against both α-glucosidase and BACE1 (IC50 = 51.27 ± 1.23 and 13.75 ± 0.26 μM; Ki value = 52.04 and 14.76 μM, respectively). Moreover, docking studies showed that luteolin formed a strong hydrogen bond with the peripheral binding amino acid residues, and hydrophobic interactions with the α-glucosidase and BACE1 enzymes. Therefore, Korean thistle may act as an important dietary supplement against diabetes and Alzheimer’s disease, especially the leaves, because of the preponderance of the active component, luteolin, making Korean thistle a promising candidate for more detailed in vitro and in vivo studies.Keywords
This publication has 59 references indexed in Scilit:
- α-glucosidase inhibitors from plants: A natural approach to treat diabetesPharmacognosy Reviews, 2011
- How does diabetes accelerate Alzheimer disease pathology?Nature Reviews Neurology, 2010
- Neuroprotective effect of luteolin on amyloid β protein (25–35)‐induced toxicity in cultured rat cortical neuronsPhytotherapy Research, 2010
- Flavonoid‐mediated presenilin‐1 phosphorylation reduces Alzheimer's disease β‐amyloid productionJournal of Cellular and Molecular Medicine, 2009
- A qualitative approach to enzyme inhibitionBiochemistry and Molecular Biology Education, 2009
- Association of Adiposity Status and Changes in Early to Mid-Adulthood With Incidence of Alzheimer's DiseaseAmerican Journal of Epidemiology, 2008
- Protein tyrosine phosphatase 1B inhibitors from Morus root barkBioorganic & Medicinal Chemistry Letters, 2006
- Proteolytic mechanisms in amyloid-β metabolism: therapeutic implications for Alzheimer's diseaseTrends in Molecular Medicine, 2005
- MDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability ScreeningJournal of Pharmaceutical Sciences, 1999
- The Determination of Enzyme Dissociation ConstantsJournal of the American Chemical Society, 1934